An advisory panel of the US Food and Drug Administration has voted to recommend emergency approval for a coronavirus vaccine developed by Pfizer, saying its benefits overcome any risks despite dissent from some committee members. The panel, part of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), voted 17-4 on Thursday to support emergency use for the inoculation, with one abstention. The principal question before the committee was whether the jab’s benefits outweighed its risks for “use in individuals 16 and older,” based on the available evidence. While the five committee members who either opposed the
Hence then, the article about fda panel says benefits outweigh risks for pfizer vaccine recommends emergency authorization in non unanimous vote was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA panel says ‘benefits outweigh risks’ for Pfizer vaccine & recommends emergency authorization in non-unanimous vote )